Introduction
Transfusion medicine deals with that part of health care system which undertakes the appropriate provision and use of human blood resources. It provides the essential scientific clinical information for transfusion practice and they link between the blood donor altruistic donation and recipients. 1 An antigen or certain substance present on red cell reacts with corresponding antibody present in the serum can cause harmful effect. 2 Antibodies that are produced after exposure to foreign antigens are termed as alloantibodies, whereas those that are produced against self antigens are known as auto antibodies.
Antibodies are globulins which are produced in response to an antigenic stimulation There are five classes of immunoglobulin: IgM, IgG, IgA, IgD, and IgE, of which, only the first two are important in blood transfusion. Red cell antibodies of the IgA class appear rarely and then almost invariably together with IgM and IgG antibodies. 2 Naturally occurring red cell antibodies are found in a person who has never received blood or blood product, or vaccines of human origin or has never been pregnant nor undergone organ transplantation. This may arise through one of two mechanism. First it seems possible that some immunocompetent cells may be capable of producing a specific antibody in the absence of an antigenic stimulus, secondly the antibodies may be produced in response to substances present in the environment and antigenically similar to blood group antigens. 2 Immune antibodies arise as a result of exposure to an alloantigen by transfusion of blood products, pregnancy, vaccination with vaccines of human origin or transplantation. The antibody that activates complement leading to cell lysis is called hemolysin antibody. Group "O' donor's plasma may contain potent anti A or anti-B, capable of reacting with the red cells of a group A, B or AB recipent and sometimes cause a severe transfusion reaction. The anitbodies may take the form of high titre agglutinins or hemolysins. Patient's blood group A, B of AB receiving "01" blood with a high titreIgG anti-A or anti-B reacting at 37° C donated by a high risk universal donor may experience a moderate transfusion reaction resulting jaundice and progressive anemia. Immune anti-A and anti-B are sometimes responsible for transfusion reaction following administration oflarge amounts of blood products. 3 Hemolytic disease of the newborn is the results of red cell alloimmunization in which IgG anybodies passage from the maternal circulation across the placenta in the circulation of the fetus where they react with fetal red calls and lead to their destruction. Anit-D anibody is responsible for most cases of severe HDN although anti-C, anti-E anti-K & a wide range of other antibodies are found in occasional cases. Although antibodies against the ABO blood group system the most frequent causes of HDN this is usually mild. Within the UK, approximately 500 fetuses develop hemolytic disease each year & approximately 30 of these cases are fatal. 4 Previously transfusion/donation/administration of blood group "0" to any patient, was considered to be of risk & a safer option. In the early years of the Second World War group "O' blood was use for all emergency transfusion in the European Countries, usually without any cross matching or other serological testing & adverse reactions were rare.
However, this perception has now recently come to a halt. It is now known that though the recipients serum may not react with the donor's red cells, group "O" donor's plasma may contain potent anti-A or anti-B, capable of reacting with the red cells of a group A, B or Ab recipient and some time can also causes severe transfusion reaction. 5 The present study was undertaken to investigate the possible differences at various titer level between two sex groups.
Methods:
This cross sectional study was done on 100 cases of "O' blood group female inchild bearing age and 100 adult male was selected as control, in transfusion medicine department, BSMMU from June 2008 to May 2009.Detailed demographic and clinical finding of all subject were recorded in data collection sheet. All analysis was done using SPSS (statistical package for social science) using inclusion & exclusion criteria. The objectives of the study along with its procedure risk and benefits of the study were explained to the subjects in easily understandable local language and then informed consent was taken from each subject. Itwas assured that all information and records would be kept confidential and the procedure would be helpful for both the attending subjects in making rational approach of the case management. This study was carried out in 200 subjects. They were divided into female and male groups. Out of which 50.0% were female and rest 50.0% were male subjects. It was found that 45(45.0%) and only 2(2.0%) had history of blood transfusion in female and male subjects respectively. The difference was found statistically significant (p<o.05) between female and male in chi square test.
Results & Observation

Table-VI Parity of the subject (n=74).
Para
Number Nulliparity was predominant in the study subjects. 
Discussion
This cross sectional study was carried out with an objective to find out thehemolysin titer of "O' blood group female and determination of significant titer range which indicate risk of hemolyitc disease of newborn.
A total of 200 healthy subject age ranged from 18 to 51 years were included in the study, in the department of transfusion medicine, in BSMMU, during the period June 2008 to May 2009.
In the present study the mean age was 27.34±6.7 years with their age ranged from 18 to 50 years in female group. In male group the mean age was 35.64±6.72 years with their age ranged from 20 to 51 years. Maximum number was found in the age group of 20-30 years in female group and 31-40 years in male group. The mean age difference was found statistically significant (p<0.05). Aubert etal. (1942) 6 showed identical age ranged in their study, which is comparable with the present study.
In the current study male ratio 1:1 which is almost consistent with Adewuyi, Gwanzura and Mvere (1994), 7 where they observed female male ration was 1:14. Regarding the marital status in this study 74.0% and 84.0% female and male were married respectively.
It was found in this study that 81.0% & 98% had Rh+ve in female and male subjects respectively, which indicates thatRh+ve was significantly (p<0.05) higher in male subjects.
In this study it was observed that 27.0% husband's had blood group A, 28.4% blood group B, 44.6% blood group O and among them 29.7% had Rh+ve. About a half (45.0%) and only 2.0% had history of blood transfusion in female and male subjects respectively. The history of blood transfusion was significantly (p<.05) in female subjects.
The mean systolic and diastolic blood pressure was 115.1+15.68 mmHg and 73.23+14.7 mmHg respectively in female group. In male subjects the mean systolic and diastolic blood pressure was 121.4+10.88 mmHg and 80.0+ 16.2 mmHg respectively. The mean blood pressure was significantly (p<0.05) higher in male subjects.
Most of the Hemolysin antibody with A cell and Hemolysin antibody with B cell were 16 and 16 respectively in female and male group.
In this study the mean Hemolysin antibody with A cell and Hemolysin antibody with B cell were 21.3± 17.9 and 26.9+21.4 respectively in female group. In male group Hemolysin antibody with A cell and Hemolysin antibody with B cell were 19.2±12.3 and 16.5+8.15 respectively. The mean Hemolysin antibody with A cell and Hemolysin antibody with B cell were found significantly (p<0.05) higher in female subject then male due to pregnancy hymolysin antibody.
Conclusion
It is important to avoid transfusion of blood containing high titres of immune anti A and anti B antibodies to non O group recipients. As per the requirements of the American Association of Blood Banks (AABB) Standards transfusion service should have a policy concerning transfusion of components containing significant amounts of ABO incompatible antibodies. Taking into consideration the finding of the present study that strongly heamolytic samples have high titres of IgG, a simple screen for donor heamolysin is suggested which can decrease the risk of transfusion if platelets/plasma from donors with minor incompatibbility aresused. Besides detecting strong heamolytic serum, the test also identifies donor who are likely to have high levels of IgG anti A and/or anti B for blood transfusion purposes.
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